{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Ozanimod  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ozanimod. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ozanimod  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "ozanimod",
    "trial_2_text": "Ozanimod  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Ozanimod Supplement: 60 participants will take Ozanimod 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ozanimod. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ozanimod  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.3415692448616028,
      "87": 0.2739136815071106,
      "9": 0.18081262707710266,
      "17": 0.1703232079744339,
      "20": 0.16951556503772736,
      "123": 0.157636821269989,
      "68": 0.1537676453590393,
      "46": 0.14945273101329803,
      "189": 0.1488712728023529,
      "173": 0.1467512547969818,
      "188": 0.14278002083301544,
      "177": 0.14218951761722565,
      "49": 0.1388649046421051,
      "67": 0.13706454634666443,
      "77": 0.12971676886081696,
      "37": 0.12137363851070404,
      "239": 0.12133590131998062,
      "200": 0.12117427587509155,
      "243": 0.12032484263181686,
      "21": 0.11130566895008087,
      "79": 0.1100149154663086,
      "228": 0.10339628905057907,
      "104": 0.10134399682283401,
      "5": 0.09647781401872635,
      "139": 0.09209167212247849,
      "64": 0.09192358702421188,
      "116": 0.09162257611751556,
      "350": 0.08913613855838776,
      "86": 0.08841126412153244,
      "38": 0.08392121642827988,
      "204": 0.08156420290470123,
      "131": 0.0804641842842102,
      "29": 0.08003782480955124,
      "14": 0.07839943468570709,
      "126": 0.07769916951656342,
      "151": 0.07427956908941269,
      "28": 0.07410608977079391,
      "193": 0.07140455394983292,
      "101": 0.07085554301738739,
      "27": 0.07047469168901443,
      "18": 0.07013261318206787,
      "30": 0.06914138793945312,
      "466": 0.0674830824136734,
      "102": 0.06687171757221222,
      "85": 0.06514620035886765,
      "114": 0.06459838896989822,
      "2": 0.06425171345472336,
      "61": 0.06420190632343292,
      "72": 0.06334848701953888,
      "454": 0.06303940713405609,
      "97": 0.06303056329488754,
      "82": 0.06286675482988358,
      "396": 0.061688393354415894,
      "147": 0.06117682904005051,
      "180": 0.06106676906347275,
      "76": 0.06068095564842224,
      "179": 0.06064663827419281,
      "341": 0.06012755632400513,
      "441": 0.06001751869916916,
      "166": 0.059990014880895615,
      "355": 0.059694770723581314,
      "286": 0.05905994400382042,
      "261": 0.05828360840678215,
      "36": 0.05746879056096077,
      "203": 0.056749675422906876,
      "382": 0.05586284026503563,
      "75": 0.055533770471811295,
      "422": 0.05460286885499954,
      "276": 0.05425846576690674,
      "508": 0.053005896508693695,
      "122": 0.052512276917696,
      "339": 0.052148252725601196,
      "92": 0.05120426416397095,
      "163": 0.050952427089214325,
      "69": 0.04997676983475685,
      "191": 0.049963220953941345,
      "35": 0.04970837011933327,
      "194": 0.04969518259167671,
      "456": 0.049678023904561996,
      "297": 0.049631018191576004,
      "98": 0.049138374626636505,
      "164": 0.04903584346175194,
      "282": 0.04902714863419533,
      "371": 0.04890327900648117,
      "132": 0.04810500144958496,
      "33": 0.04764707013964653,
      "352": 0.04694262146949768,
      "15": 0.04552142322063446,
      "138": 0.045369263738393784,
      "186": 0.044461436569690704,
      "105": 0.04312164708971977,
      "195": 0.04305759072303772,
      "118": 0.04260590672492981,
      "288": 0.04214223474264145,
      "363": 0.04210049659013748,
      "256": 0.04206245765089989,
      "262": 0.04169012978672981,
      "269": 0.041493628174066544,
      "152": 0.04132672771811485,
      "253": 0.040780868381261826
    },
    "trial_2_ae": {
      "78": 0.3415692448616028,
      "87": 0.2739136815071106,
      "9": 0.18081262707710266,
      "17": 0.1703232079744339,
      "20": 0.16951556503772736,
      "123": 0.157636821269989,
      "68": 0.1537676453590393,
      "46": 0.14945273101329803,
      "189": 0.1488712728023529,
      "173": 0.1467512547969818,
      "188": 0.14278002083301544,
      "177": 0.14218951761722565,
      "49": 0.1388649046421051,
      "67": 0.13706454634666443,
      "77": 0.12971676886081696,
      "37": 0.12137363851070404,
      "239": 0.12133590131998062,
      "200": 0.12117427587509155,
      "243": 0.12032484263181686,
      "21": 0.11130566895008087,
      "79": 0.1100149154663086,
      "228": 0.10339628905057907,
      "104": 0.10134399682283401,
      "5": 0.09647781401872635,
      "139": 0.09209167212247849,
      "64": 0.09192358702421188,
      "116": 0.09162257611751556,
      "350": 0.08913613855838776,
      "86": 0.08841126412153244,
      "38": 0.08392121642827988,
      "204": 0.08156420290470123,
      "131": 0.0804641842842102,
      "29": 0.08003782480955124,
      "14": 0.07839943468570709,
      "126": 0.07769916951656342,
      "151": 0.07427956908941269,
      "28": 0.07410608977079391,
      "193": 0.07140455394983292,
      "101": 0.07085554301738739,
      "27": 0.07047469168901443,
      "18": 0.07013261318206787,
      "30": 0.06914138793945312,
      "466": 0.0674830824136734,
      "102": 0.06687171757221222,
      "85": 0.06514620035886765,
      "114": 0.06459838896989822,
      "2": 0.06425171345472336,
      "61": 0.06420190632343292,
      "72": 0.06334848701953888,
      "454": 0.06303940713405609,
      "97": 0.06303056329488754,
      "82": 0.06286675482988358,
      "396": 0.061688393354415894,
      "147": 0.06117682904005051,
      "180": 0.06106676906347275,
      "76": 0.06068095564842224,
      "179": 0.06064663827419281,
      "341": 0.06012755632400513,
      "441": 0.06001751869916916,
      "166": 0.059990014880895615,
      "355": 0.059694770723581314,
      "286": 0.05905994400382042,
      "261": 0.05828360840678215,
      "36": 0.05746879056096077,
      "203": 0.056749675422906876,
      "382": 0.05586284026503563,
      "75": 0.055533770471811295,
      "422": 0.05460286885499954,
      "276": 0.05425846576690674,
      "508": 0.053005896508693695,
      "122": 0.052512276917696,
      "339": 0.052148252725601196,
      "92": 0.05120426416397095,
      "163": 0.050952427089214325,
      "69": 0.04997676983475685,
      "191": 0.049963220953941345,
      "35": 0.04970837011933327,
      "194": 0.04969518259167671,
      "456": 0.049678023904561996,
      "297": 0.049631018191576004,
      "98": 0.049138374626636505,
      "164": 0.04903584346175194,
      "282": 0.04902714863419533,
      "371": 0.04890327900648117,
      "132": 0.04810500144958496,
      "33": 0.04764707013964653,
      "352": 0.04694262146949768,
      "15": 0.04552142322063446,
      "138": 0.045369263738393784,
      "186": 0.044461436569690704,
      "105": 0.04312164708971977,
      "195": 0.04305759072303772,
      "118": 0.04260590672492981,
      "288": 0.04214223474264145,
      "363": 0.04210049659013748,
      "256": 0.04206245765089989,
      "262": 0.04169012978672981,
      "269": 0.041493628174066544,
      "152": 0.04132672771811485,
      "253": 0.040780868381261826
    }
  },
  "safety": {
    "trial_1_safety": 0.32230064272880554,
    "trial_2_safety": 0.32230064272880554
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47661179304122925
  }
}